Prot #6R88-COV-2040: An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients with COVID-19
- Wunderink, Richard G (PD/PI)
Project: Research project
Project: Research project